Gestational age, sex and maternal parity correlate with bone turnover in premature infants

被引:11
作者
Aly, H
Moustafa, MF
Amer, HA
Hassanein, S
Keeves, C
Patel, K
机构
[1] George Washington Univ, Dept Neonatol, Washington, DC USA
[2] Childrens Natl Med Ctr, Washington, DC 20010 USA
[3] Ain Shams Univ, Sch Med, Dept Pediat, Cairo, Egypt
[4] Ain Shams Univ, Sch Med, Dept Clin Pathol, Cairo, Egypt
[5] Childrens Natl Med Ctr, Dept Biostat, Washington, DC 20010 USA
关键词
D O I
10.1203/01.PDR.0000160591.70409.C8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Factors affecting bone turnover in premature infants are not entirely clear but certainly are different from those influencing bones of adults and children. To identify fetal and maternal factors that might influence bone turnover, we prospectively studied 50 infants (30 preterm and 20 full-term) born at Ain Shams University Obstetric Hospital in Cairo, Egypt. Maternal parity and medical history and infant's weight, gestational age, gender and anthropometrical measurements were recorded. Cord blood samples were collected and serum type I collagen G terminal propeptide (PICP) was assessed as a marker for fetal bone formation. First morning urine samples were collected and pyridinoline cross-links of collagen (Pyd) were measured as an index for bone resorption. Serum PICP was higher in premature infants when compared with full-term infants (73.30 +/- 15.1 versus 64.3 +/- 14.7, p = 0.022) and was higher in male premature infants when compared with females (81.64 +/- 9.06 versus 66.0 +/- 15.7, p = 0.018). In a multiple regression model using PICP as the dependent variable and controlling for different infant and maternal conditions, PICP significantly correlated with infant gender (r = 8.26 +/- 4.1, p = 0.05) maternal parity (r = -2.106 +/- 0.99, p = 0.041) and diabetes (r = 22.488 8.73, p = 0.041). Urine Pyd tended to increase in premature infants (612 +/- 308 versus 434 +/- 146, p = 0.057) and correlated significantly with gestational age (r = -63.93 +/- 19.55, p = 0.002). Therefore, bone formation (PICP) is influenced by fetal age and gender, as well as maternal parity and diabetes. Bone resorption (Pyd) is mostly dependent on gestational age only. Further in-depth studies are needed to enrich management of this vulnerable population.
引用
收藏
页码:708 / 711
页数:4
相关论文
共 24 条
  • [1] NEW BALLARD SCORE, EXPANDED TO INCLUDE EXTREMELY PREMATURE-INFANTS
    BALLARD, JL
    KHOURY, JC
    WEDIG, K
    WANG, L
    EILERSWALSMAN, BL
    LIPP, R
    [J]. JOURNAL OF PEDIATRICS, 1991, 119 (03) : 417 - 423
  • [2] Bradbeer J. N., 1992, RECENT ADV ENDOCRINO, P95
  • [3] Bone and collagen markers in preterm infants: Relationship with growth and bone mineral content over the first 10 weeks of life
    Crofton, PM
    Shrivastava, A
    Wade, JC
    Stephen, R
    Kelnar, CJH
    Lyon, AJ
    McIntosh, N
    [J]. PEDIATRIC RESEARCH, 1999, 46 (05) : 581 - 587
  • [4] ERIKSEN EF, 1993, J BONE MINER RES, V8, P127
  • [5] Fraser WD, 1998, J CLIN LIGAND ASSAY, V21, P102
  • [6] URINARY PYRIDINOLINE AND DEOXYPYRIDINOLINE IN HEALTHY-CHILDREN AND IN CHILDREN WITH GROWTH-HORMONE DEFICIENCY
    FUJIMOTO, S
    KUBO, T
    TANAKA, H
    MIURA, M
    SEINO, T
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (06) : 1922 - 1928
  • [7] GANONG WF, 2000, REV MED PHYSL, P365
  • [8] Urinary excretion of pyridinium crosslinks and N-terminal crosslinked peptide in preterm and term infants
    Gfatter, R
    Braun, F
    Herkner, K
    Kohlross, C
    Hackl, P
    [J]. INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1997, 27 (04) : 238 - 243
  • [9] Effects of gestational age, maternal diabetes, and intrauterine growth retardation on markers of fetal bone turnover in amniotic fluid
    Harrast, SD
    Kalkwarf, HJ
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1998, 62 (03) : 205 - 208
  • [10] Urinary excretion of pyridinium crosslinks in healthy 4-10 year olds
    Husain, SM
    Mughal, Z
    Williams, G
    Ward, K
    Smith, CS
    Dutton, J
    Fraser, WD
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 80 (04) : 370 - 373